CL analyst estimates
Colgate-Palmolive (CL) analyst ratings, the average price target and its range, and every firm's latest call.
CL analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 15, 2026 | UBS | Colgate-Palmolive price target lowered to $106 from $109 at UBS | $106.00 |
| Sep 21, 2026 | Piper Sandler | Colgate-Palmolive price target lowered to $95 from $98 at Piper Sandler | $95.00 |
| Aug 3, 2026 | UBS | Colgate-Palmolive price target raised to $109 from $106 at UBS | $109.00 |
| Aug 3, 2026 | Morgan Stanley | Colgate-Palmolive price target raised to $104 from $100 at Morgan Stanley | $104.00 |
| Aug 3, 2026 | Deutsche Bank | Colgate-Palmolive price target raised to $101 from $99 at Deutsche Bank | $101.00 |
| Aug 3, 2026 | RBC Capital | Colgate-Palmolive price target raised to $104 from $102 at RBC Capital | $104.00 |
| Jul 8, 2026 | Wells Fargo | Colgate-Palmolive price target raised to $95 from $92 at Wells Fargo | $95.00 |
| Jun 11, 2026 | Bernstein | Colgate-Palmolive initiated with Market Perform on valuation at Bernstein | $96.00 |
| May 4, 2026 | Deutsche Bank | Colgate-Palmolive price target raised to $99 from $98 at Deutsche Bank | $99.00 |
| May 4, 2026 | UBS | Colgate-Palmolive price target raised to $100 from $98 at UBS | $100.00 |
| Apr 21, 2026 | Redburn Partners | Colgate-Palmolive upgraded to Buy from Neutral at Rothschild & Co Redburn | $100.00 |
| Apr 14, 2026 | Barclays | Colgate-Palmolive price target lowered to $79 from $88 at Barclays | $79.00 |
| Apr 9, 2026 | RBC Capital | Colgate-Palmolive price target lowered to $102 from $104 at RBC Capital | $102.00 |
| Apr 8, 2026 | Wells Fargo | Colgate-Palmolive price target lowered to $92 from $100 at Wells Fargo | $92.00 |
| Apr 8, 2026 | Piper Sandler | Colgate-Palmolive price target lowered to $92 from $96 at Piper Sandler | $92.00 |
- 16 firms rate CL: 10 buy, 6 hold, 0 sell.
- The average price target is $100.14 from 7 analysts, from $95.00 to $106.00.
Updated 2026-11-02 17:12 UTC